通过促进E2F1和FOXM1的结合,CDCA5加速乳腺癌的进展
Yiquan Xiong1, Lan Shi1, Lei Li1
1Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Road, Wuhan, Hubei, 430022, China.
Journal of translational medicine
|July 8, 2024
概括
细胞分裂周期相关的5 (CDCA5) 通过调节FOXM1/Wnt轴促进乳腺癌的进展. 向CDCA5可能为乳腺癌治疗提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 乳腺癌是女性普遍存在的恶性瘤.
- 与细胞分裂周期相关的5 (CDCA5) 在各种癌症中被上调.
- CDCA5在乳腺癌中的作用需要进一步研究.
研究的目的:
- 探索CDCA5在乳腺癌中的功能和调节机制.
- 确定CDCA5表达和患者预后之间的关联.
- 为了阐明参与CDCA5-介导乳腺癌进展的分子途径.
主要方法:
- 乳腺癌样本的免疫组织化学染色.
- 分析CDCA5表达与临床病理特征和预后的相关性.
- 在体外和体内研究使用CDCA5过度表达/敲击模式.
- 同免疫沉,ChIP和双露西法酶记者测定.
- 西式抹杀和定量实时PCR.
主要成果:
- CDCA5在乳腺癌组织和细胞系中过度表达,与预后不佳相关.
- 降低CDCA5抑制了繁殖和迁移,同时促进了细胞亡.
- 通过促进E2F1与FOXM1促进体结合,CDCA5促进乳腺癌的进展.
- 缺少FOXM1减轻了CDCA5过度表达的影响.
- Wnt/β-catenin信号通路对于CDCA5诱导的乳腺癌进展至关重要.
结论:
- CDCA5通过CDCA5/FOXM1/Wnt信号轴促进乳腺癌的进展.
- CDCA5代表了乳腺癌的一个潜在的新疗法标.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cadherins in Tissue Organization
3.0K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.0K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


